Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294383 · ClinicalTrials.gov registry record
Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 138
- Enrollment target
NCT02294383: Completed study, sponsored by Artann Laboratories.
NCT02294383 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02294383 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The clinical study includes investigation of the outcomes of surgery for biomechanical restoration of pelvic floor conditions, monitoring pelvic floor conditions under conservative treatment/management, identification and investigation changes of pelvic floor muscle contractions and their significance in characterization of pelvic floor conditions, assessment of tactile imaging reproducibility, including pelvic floor muscle contraction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-01 |
What the finished NCT02294383 record still lists
NCT02294383 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02294383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02294383 about?
NCT02294383 is a clinical study titled "Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions". The clinical study includes investigation of the outcomes of surgery for biomechanical restoration of pelvic floor conditions, monitoring pelvic floor conditions under conservative treatment/management, identification and investigation changes of pelvic floor muscle contractions and their significan...
What is the current status of trial NCT02294383?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2014-08. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02294383?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia